Mounjaro®
Starting from £179.99/mo
Start journey Learn moreDrinking alcohol while on semaglutide is not flatly prohibited, but the combination carries real risks that most people don't anticipate. Semaglutide slows gastric emptying and alters appetite signals, which changes how your body handles alcohol — often making its effects feel stronger and arrive faster. These are prescription-only medicines requiring clinical assessment; your prescriber is best placed to advise you based on your individual health picture.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The most common misconception our prescribers hear is that semaglutide only affects hunger, so alcohol sits in a separate lane and can be managed the same way it always was. That isn't quite right. Semaglutide (the active medicine in Wegovy) slows the rate at which your stomach empties. Food and drink both pass more slowly into the small intestine, which is where alcohol enters the bloodstream. Slower gastric emptying means alcohol may be absorbed less evenly and, in some situations, more unpredictably. If you want a fuller picture of how these interactions play out day to day, the guidance on whether you can drink on semaglutide walks through the key considerations in detail.
There's also the nausea factor. Gastrointestinal side effects (queasiness, bloating, an unsettled stomach) are the most commonly reported reactions to semaglutide, particularly in the first weeks or after a dose increase. Alcohol is itself an irritant to the stomach lining. The two together can amplify nausea significantly. The NHS semaglutide medicines page notes that alcohol can make side effects worse and that patients should discuss their drinking habits with their prescriber before starting.
None of this makes a glass of wine a medical emergency. It does mean 'as normal' is probably the wrong frame.
Alcohol has a complicated relationship with blood sugar. It can cause glucose to fall (sometimes sharply) particularly in people on medicines that already affect glucose handling. Semaglutide is used for weight management and, in some patients, alongside type 2 diabetes management; in either context, unpredictable blood sugar swings are worth taking seriously. If you are managing diabetes alongside your weight, the risk of hypoglycaemia after drinking is higher and you should discuss safe limits explicitly with your prescriber.
Calories are the other consideration. Alcohol is energy-dense (roughly 7 kcal per gram, more than carbohydrate or protein) and those calories arrive without the satiety signals that food triggers. Semaglutide works in part by extending the feeling of fullness after eating. Alcohol bypasses that mechanism. Regular drinking, even in moderate amounts, can quietly offset a meaningful share of the calorie deficit that treatment helps create. For context on how treatment fits into a broader weight management plan, the weight loss treatments overview covers the lifestyle elements that support best outcomes.
The practical upshot: occasional, moderate drinking is unlikely to derail treatment. Regular or heavy drinking is a different calculation, and one worth raising directly at your consultation.
Some people on semaglutide (and GLP-1 medicines more broadly) report that their interest in alcohol drops. This has attracted considerable attention, and early research suggests the brain's reward pathways may be involved. It's a genuine observation, not a marketing claim. However, it is not consistent across everyone, it is not a licensed use of semaglutide, and it absolutely should not be treated as a reason to assume the medicine is protecting you against alcohol's effects. If anything, the mechanism that might reduce cravings is separate from (and does not counteract) the gastric-emptying and blood-sugar dynamics described above.
If you have concerns about alcohol use alongside treatment, that is exactly the kind of thing to raise with your prescriber. For questions about other situations where semaglutide's effects interact with daily life, the guidance on semaglutide during pregnancy and Wegovy's cardiovascular evidence cover two other areas where context matters a great deal.
There is no official 'zero alcohol' rule for semaglutide in the UK prescribing guidance. What exists is a clear steer to be cautious, drink less than you might otherwise, eat before drinking, and never drink on an empty stomach while on treatment. Keeping your Wegovy pen in the fridge door as part of your weekly routine is a good prompt to think about that week's plans, including whether a social event means adjusting how you eat beforehand.
If you experience dizziness, severe nausea, or signs of low blood sugar after drinking, seek medical advice. For anything that feels like a serious reaction (including severe or persistent stomach pain) call 111 or attend an urgent care centre. You can also report unexpected reactions via the MHRA's Yellow Card scheme, which monitors the safety of medicines including semaglutide. Questions about specific wines or spirits come up often enough that there's a dedicated page on drinking wine on semaglutide if that's the context you're in. More general questions about alcohol and this treatment are covered on the Wegovy and alcohol page.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.